Fareston prescribing information |
|
 |
|
Fareston description
The generic name of Fareston is Toremifene and it is indicated to slow down the progress of metastatic breast cancer, which spreads from a tumour. Its main function is to restrict estrogen from reaching cancer cells thus preventing the cells from growing. However, Fareston does not destroy the cancer cells and only restricts its growth. Other than breast cancer, it is also beneficial in cases of prostate cancer and people who are dealing with pregnancy should avoid it. The advised intake of Fareston is 60 mg in a single day. In the year 1995, Fareston was approved by US Food and Drug Administration for medicinal use.
Description
Fareston is used for the treatment of problems like metastatic breast cancer in women with unknown tumours positive-estrogen-receptor. This medicinal drug has the main functions of stopping cancer cells from growing in the body by restricting the flow of female hormone oestrogen.
Dosage
Normal prescription on Fareston is 60 mg in a single day with a full glass of water. Usually it is advised to consume the medicine at the same time each day and it can be consumed with or without water.
Interactions
Certain blood thinning medicines like nicoumalone and warfarin have enhanced effects when consumed along with Fareston. antiepileptics carbamazepine, phenobarbital and phenytoin have the tendency to decrease effect of Fareston in blood by reducing the level of toremifene in blood.
Caution
The person who is consuming Fareston along with thiazide diuretics is at increased risk of hypercalcaemia. One should limit or stop the consumption of alcohol and other substances like nicotine and caffeine to reduce the side effects caused by Fareston like sweating and flashes.
Side Effects
There are different side effects of Fareston on different people depending on their physical nature. However, it may not be necessary that all of the people who are consuming the medicine may feel side effects. Below mentioned are basic side effects of Fareston:
• Skin pigmentation problems
• Headache
• Abnormal sweating
• Fatigue
• Abnormal sweating
• High level of calcium deposits in blood
• Vomiting and Nausea
• Dizziness
• Vaginal bleeding
• Swelling due to excessive fluid retention in body
• White fluid discharging from Vagina
• Pain
Fareston notes:
Fareston (toremifene), used to treat breast cancer in women, is now sold under the brand name of Fareston. Fareston is useful in women who are in the post menopause stage. Fareston shrinks the cancer and prevents it from spreading in the body. Research is being pursued on “Fareston prostate cancer” and new breakthroughs are expected in the coming months. Similar research is being done Fareston’s bodybuilding effects. Your doctor should prescribe this drug to you and it should be taken only with your doctor’s advice.
Some of the side affects that have been reported as a result of the use of Fareston are skin color change, headaches, weight gain, sweating, hot flushes, bleeding, and nausea. Swelling caused due to fluid retention, weight gain, pain, and exhaustion are some other side affects reported by the users of Fareston. These side affects may or may not be true for all users of Fareston. Individuals are different as far as their body constitution is concerned and hence the side affects may also vary.
Alcohol, caffeine, and smoking are to be avoided or refrained from during the use of Fareston. The doctor would normally recommend you to take Fareston once a day. Typical Fareston dosage is 60 mg white tablet accompanied with a glass full of water. It is best if Fareston is taken at the same time everyday and Fareston can be taken with or without meals. For Fareston buy, get Fareston’s prescription information and order now. Confirm the genuinity by checking Fareston label.
Exercise helpful for lymphoma patients – says researchers
Researchers at University of Alberta have found that daily exercise can prove to be helpful for lymphoma patients receiving chemotherapy. A three year study shows significant improvements in physical functioning and overall quality of life benefits in patients with lymphoma. 122 participants with Hodgkin's and non-Hodgkin's lymphoma were included for this study. They were distributed in groups by disease type and treatment status that whether they were undergoing chemotherapy at the time or receiving no treatments.
Participants were randomly assigned to an exercise program designed to maximize cardiovascular fitness. The participants were asked to under go exercise three times a week that lasts for almost twelve weeks. Lymphoma patients who received the exercise intervention reported significant improvement in physical functioning, overall quality of life, less fatigue, increased happiness, less depression and an improvement in lean body mass. The group receiving chemotherapy benefited as much as the group that was off the treatments.
Kerry Courneya, Canada Research Chair in physical activity and cancer in the Faculty of Physical Education and Recreation who led this study said that vigorous intensity exercise program did not interfere with lymphoma patients ability to complete their chemotherapy treatments. He further added to found that 46.4 per cent of patients in the exercise group had a complete response to their treatment compared to only 30.8 per cent in the usual care group.
Curr Opin Support Palliat Care. 2010 Jun 28. [Epub ahead of print]
Kim HS
Side effects and administration of androgen in prostate cancer
Anticancer Res. 2010 Apr;30(4):1243-9.
Muftuler FZ et all.
Department of Nuclear Applications, Institute of Nuclear Sciences, Ege University, Izmir, Turkey.
Management of anti oestrogen glucuronide compound
Gan To Kagaku Ryoho. 2010 May;37(5):899-902.
Okamoto et all.
Reactivation of breast cancer after treatment with chemotherapy and endocrine
Gan To Kagaku Ryoho. 2009 Nov;36(12):2484-6.
Sakurai K et all.
Successful treatment of breast cancer with paclitaxel and toremifine therapy
Gan To Kagaku Ryoho. 2009 Nov;36(12):1994-6.
Sakurai K et all.
Impact of paclitaxel and toremifene for metastatic breast cancer
Cancer Biother Radiopharm. 2009 Dec;24(6):707-16.
Yurt A et all.
Synthesis of a novel antiestrogen radioligand (99mTc-TOR-DTPA)
Gan To Kagaku Ryoho. 2008 Nov;35(12):2222-4.
Sakurai K et all.
Recurrence of skin and lymph nodes from asynchronous breast cancer successfully treated with paclitaxel and toremifene therapy--a case report.
Gan To Kagaku Ryoho. 2008 Nov;35(12):2219-21.
Sakurai K at all.
A case of advanced breast cancer successfully treated with paclitaxel and toremifene therapy
Int J Oncol. 2008 Oct;33(4):791-8.
Toffanin S et all.
Clusterin: a potential target for improving response to antiestrogens
Fareston review article...
|
|
Anti-cancer drugs
 Fareston prescribing information
Buy here
|
|
My Basket
